| Description | Docaravimab, an antibody designed to target the G-III epitope within the ectodomain of the Evelyn-Rockitniki-Abelseth (ERA) glycoprotein, is utilized in rabies research [1]. |
| molecular weight | N/A |
| CAS | 2247196-23-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |